Home care
 

Keywords :   


Tag: care

KEYTRUDA (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma

2015-10-09 13:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KEYTRUDA is Currently Approved in 39 Countries, including the United States and throughout the European Union KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the National Institute for Health and Care Excellence (NICE) of the United Kingdom (U.K.) has issued a draft recommendation, in the form of a Final Appraisal Determination (FAD), recommending KEYTRUDA (pembrolizumab) as a first-line treatment option for adults with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-236-1130orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for advanced health care

 

China: The Hidden Dragon of Pro Skin Care Market

2015-10-08 18:00:00| Happi Breaking News

Klines newest data also shows resurrection in Europe.

Tags: pro care china market

 
 

Wen Expands With Body Care

2015-10-08 07:00:00| Happi Breaking News

'Sixthirteen' formulation features arnica and vitamin K.

Tags: care body wen expands

 

Galderma Rolls Out Therapeutic Skin Care Line

2015-10-08 07:00:00| Happi Breaking News

Excipial topicals and oral supplement are engineered for challenged skin.

Tags: line care skin therapeutic

 

Lubrizol Introduces New Home Care Solutions

2015-10-08 07:00:00| Happi Breaking News

Booth at annual cleaning products conference.

Tags: home care solutions introduces

 

Sites : [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] next »